NewsRoom Articles

TuesdayApr 16, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Global Patent Portfolio to 41; Maintains Focus on GLP-1 Clinical Studies for 2024

Lexaria, a global innovator in drug delivery platforms, has added three new patents to its portfolio, bringing the total to 41 Two patents were awarded in the U.S., while the third was awarded in Japan, expiring in 2042 and 2041, respectively, if not extended Lexaria’s management plans to maintain focus on GLP-1 studies for 2024 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, in the month of April 2024, added three new patents to its portfolio. This brings the total number of awarded patents globally to 41, a testament to the versatility of its patented DehydraTECH(TM) technology…

FridayApr 12, 2024 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Offers Versatile and Reliable Cross-Border Logistics in the USMCA Region Amid Railroad Disruptions

Temporary railroad shutdowns in December 2023 stranded nearly 10,000 rail cars on both sides of the U.S. and Mexico border with embargoed goods on over 60 trains With disruptions to cross-border trade on the rise, companies are seeking more reliable ways to organize, facilitate, and monitor their cross-border shipments Fr8Tech, a tech company on a mission to revolutionize cross-border shipping, has positioned itself as the go-to brand for such services through its Fr8App system Fr8App seamlessly connects shippers with carriers and drivers, and offers comprehensive real-time tracking, fleet management, live pricing, and transportation management The ongoing migrant crisis has exposed…

ThursdayApr 11, 2024 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Bolsters C-Suite with New CFO Appointment

Lexaria, a global innovator in drug delivery platforms, has announced the appointment of Nelson Cabatuan, CPA, as its new CFO Nelson will lend over 15 years of experience in corporate finance and operations, having worked in key organizations within the industry, and will play an integral role in supporting upcoming GLP-1 human clinical studies and overseeing key financial areas of the company The appointment highlights Lexaria’s confidence in its recently confirmed focus on important GLP-1 studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced the appointment of Nelson Cabatuan, CPA, as its new Chief Financial…

MondayApr 08, 2024 11:15 am

Diamond Lake Minerals Inc. (DLMI) Continues to Leverage Tokenization to Open New Opportunities for Investors Globally

DLMI, a multi-strategy operating company, is tapping into expanding digital securities and global blockchain industries by asserting itself as a trusted authority in the tokenization space In an interview with Proactive’s Stephen Gunnion, Brian J. Esposito, DLMI’s CEO, noted how tokenization is redefining investing by opening up global markets to real-world assets He reiterated his goal to build strong earnings, provide shareholder value with sustainable, healthy growth, and grow the DLMI brand Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company specializing in the development and support of digital assets and SEC-registered tokens, is looking to capitalize on the growing…

ThursdayApr 04, 2024 9:00 am

Diamond Lake Minerals Inc. (DLMI) Is Actively Involved in the Potentially Revolutionary ‘Next Generation for Markets’

Tokenization, the process of developing and issuing a digital asset representing a real-world asset, is gaining recognition, as BlackRock CEO Larry Fink states that it will be the “next generation for markets” Brian J. Esposito, the CEO of multi-strategy operating company Diamond Lake Minerals, shares Fink’s vision and regards tokenization as a game-changing concept for investors Esposito believes tokenized assets provide opportunities to people who would have never had a chance to directly own such assets or participate in offerings DLMI hopes to capture a significant market share by offering SEC-registered tokens, appealing to investors who might be reticent to…

MondayMar 25, 2024 12:45 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires Contract Research Organization to Perform Important GLP-1 Human Pilot Study

Lexaria, a global innovator in drug delivery platforms, recently hired a Contract Research Organization to perform their second GLP-1 human pilot study which will test a dissolvable DehydraTECH-GLP-1 oral dose formulation The announcement follows Lexaria’s WEIGHT-A24-1 animal study announcement examining diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and cannabidiol alone and in combination The move aligns with the company’s resolve to focus on their ability to enhance the delivery of GLP-1 diabetes and obesity drugs At the beginning of the year, Lexaria Bioscience (NASDAQ: LEXX), a global innovator for enhanced drug delivery platforms, announced its intention to double…

MondayMar 25, 2024 11:15 am

Diamond Lake Minerals Inc. (DLMI) Recognizes Tokenization As The Future of Financial Markets

Larry Fink, CEO of BlackRock, foresees a future where every financial asset is tokenized Tokenization promises a future where investing is more efficient, transparent, and accessible, ultimately reshaping the financial landscape Diamond Lake Minerals employs state-of-the-art technology to develop and support digital assets and SEC-registered security tokens – setting new industry standards for security and compliance The cryptocurrency frenzy may overshadow a quieter yet monumental revolution in finance: the tokenization of financial assets. This movement, powered by blockchain technology, aims to digitize and securely represent assets like stocks, bonds, and real estate, eliminating intermediaries and streamlining transactions. Diamond Lake Minerals (OTC:…

MondayMar 25, 2024 9:45 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Helps Lead the Electric Boating Revolution, Establishes Partnership with Key Distributor

Electric boats offer an impressive list of benefits for boating enthusiasts New partnership establishes exclusive distributorship agreement for south Florida, includes “milestone” order for VMAR’s Phantom Nautical Ventures Marine Group has ordered 50 units of VMAR’s Phantom, a boat constructed from fully recyclable materials The advantages of electric propulsion are spreading beyond the roads to the waterways. Boat enthusiasts see the importance of sustainability as they consider electric boats, but they are recognizing other perks as well. The swell of support for electric boats can be seen in many ways, including the recent news from Vision Marine Technologies (NASDAQ: VMAR), a…

ThursdayMar 21, 2024 12:00 pm

Diamond Lake Minerals Inc. (DLMI) Announces Investment in Avrio Worldwide PBC Amidst Avrio’s Acquisition of HUMBL and SocialTrader

Diamond Lake Minerals purchased a 24% stake in Avrio Worldwide PBC in a strategic investment opportunity Avrio has partnered with HUMBL Financial to acquire the HUMBL Financial brand, products, and services Avrio also announced a 1:10 share exchange agreement, resulting in a bi-directional common stock acquisition between the company and SocialTrader.AI SocialTrader will deploy Avrio's digital financial market infrastructure to access public, private, and digital markets across multiple asset classes Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company on a path to emerging as a pioneering force in the development of digital assets and SEC-registered security tokens, recently announced…

ThursdayMar 21, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Achieves 7% Weight Loss; Sets Stage for 8-week Diabetes and Weight Loss Animal Study

Lexaria, a global innovator in drug delivery platforms, highlighted results from its DIAB-A22-1 animal study, highlighting a 7% reduction in weight and a 19.9% reduction in blood glucose With this success, Lexaria looks to kick off its WEIGHT-A24-1 animal study to examine diabetes and weight loss effects of its patented DehydraTECH(TM)-processed GLP-1 drugs and DehydraTECH-processed CBD The study will comprise 12 arms and involve 72 animals. It will run for a total of 12 weeks This study will build on previous studies that evidenced DehydraTECH’s potential to enable greater penetration of GLP-1 drugs into the brain tissue Lexaria Bioscience (NASDAQ:…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (310) 299-1717